Literature DB >> 10857977

Use of influenza and pneumococcal vaccines in people with diabetes.

S A Smith1, G A Poland.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10857977     DOI: 10.2337/diacare.23.1.95

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  41 in total

Review 1.  Standards of medical care in diabetes--2012.

Authors: 
Journal:  Diabetes Care       Date:  2012-01       Impact factor: 19.112

2.  Standards of medical care in diabetes--2011.

Authors: 
Journal:  Diabetes Care       Date:  2011-01       Impact factor: 19.112

Review 3.  Dissecting the interaction between COVID-19 and diabetes mellitus.

Authors:  Ying Jie Chee; Seng Kiong Tan; Ester Yeoh
Journal:  J Diabetes Investig       Date:  2020-08-05       Impact factor: 4.232

4.  Standards of medical care in diabetes--2009.

Authors: 
Journal:  Diabetes Care       Date:  2009-01       Impact factor: 19.112

5.  Standards of medical care in diabetes--2010.

Authors: 
Journal:  Diabetes Care       Date:  2010-01       Impact factor: 19.112

6.  Standards of medical care in diabetes--2013.

Authors: 
Journal:  Diabetes Care       Date:  2013-01       Impact factor: 19.112

7.  Antibody Responses to Immunizations in Children with Type I Diabetes Mellitus: a Case-Control Study.

Authors:  Michael Eisenhut; Alexander Chesover; Ronald Misquith; Nisha Nathwani; Andrew Walters
Journal:  Clin Vaccine Immunol       Date:  2016-11-04

8.  Young and elderly patients with type 2 diabetes have optimal B cell responses to the seasonal influenza vaccine.

Authors:  Daniela Frasca; Alain Diaz; Maria Romero; Nicholas V Mendez; Ana Marie Landin; John G Ryan; Bonnie B Blomberg
Journal:  Vaccine       Date:  2013-05-25       Impact factor: 3.641

9.  Influenza vaccine for cardiovascular risk reduction.

Authors:  Patricia A Howard; James W Kleoppel
Journal:  Hosp Pharm       Date:  2013-11

10.  Treat to goal: impact of clinical pharmacist referral service primarily in diabetes management.

Authors:  Thomas M Henry; Steven Smith; Michael Hicho
Journal:  Hosp Pharm       Date:  2013-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.